Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |